Skip to content

Healthcare companies and projects

Explore healthcare companies and projects across pharmaceuticals, biotechnology, medical equipment, care services and health-data infrastructure. Browse public profiles and the evaluations available on Orbitrum, then discover the experts behind the research.

Projects in Healthcare

1,515 projects

Beijing Wantai Biological Pharmacy Enterprise CoBeijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides diagnostic assays, such as high-value Hepatitis B core antibody tests, Hepatitis E Urine tests, Hepatitis D virus detection, IL-6, HIV 4th generation CLIA, Helicobacter pylori antibody, gastrin-17, and soluble transferrin receptor assays; and enzyme-linked immunosorbent assay (ELISA), colloidal gold, molecular, clinical laboratory quality control products, and bioactive materials for various infectious diseases, such as HIV, Hepatitis, Tuberculosis, and Influenza A/B. In addition, the company offers core diagnostic solutions comprising chronic disease management, integrated Hepatitis E screening and prevention, full lifecycle women's health programs, and intelligent laboratory services. Further, it provides medical instruments, diagnostic tests, quality control products, bioactive materials, and diagnostics solutions; and HPV, Hepatitis E, and Nasal Spray COVID-19 vaccines. The company was founded in 1991 and is headquartered in Beijing, China. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a subsidiary of Yangshengtang Co., Ltd.Web2
Betta PharmaBetta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China and internationally. The company offers Icotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat first-line treatment of locally advanced or non-small-cell lung cancer (NSCLC); Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of NSCLC; and Bevacizumab, an antibody drug against human vascular endothelial growth factor that is used to treat NSCLC, colorectal cancer, and other solid tumor indications. It also develops BPI-D0316, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) targeting T790M mutation; EYP-1901, an investigational long-acting treatment for wet AMD, non-proliferative diabetic retinopathy, diabetic macular edema, and pmCNV; and MCLA-129, a bispecific antibody targeting both EGFR and c-Met. In addition, the company develops BPI-371153 for the treatment of patients with locally advanced or metastatic solid tumor or relapsed/refractory lymphoma; CFT8919, an in vitro and in vivo model of EGFR L858R-driven NSCLC; and Balstilimab, a human monoclonal antibody targeting programmed cell death protein 1 and an immune checkpoint inhibitor. Further, it develops a recombinant human serum albumin injection under the OsrHSA name; and products for the treatment of solid tumor under the BPI-452080, MRX2843, BPI-460372, BPI-221351, BPI-520105, BPI-572270, and BPI-585725 names. The company was founded in 2003 and is headquartered in Hangzhou, China.Web2

Learn how to assess projects in this field with Orbitrum Academy.

About this sector

Healthcare includes both medical businesses and projects supporting how health information or research is managed. Its application sub-sectors cover pharmaceuticals, biotechnology and medical research, healthcare equipment and providers, medical records, research transparency, supply-chain transparency and patient-data privacy.

How to compare projects

A drug developer, a device supplier, a care provider and a health-data project have different activities. Use the sub-sector to establish that context, then read the actual evaluation rather than assuming a score describes every aspect of the business. This collection is for project research, not for choosing a medical treatment.

Projects follow the categories assigned in the Orbitrum application. This collection supports research and discovery; it is not an investment ranking.

Industry definitions

Healthcare Equipment & Supplies (1,090)

Suppliers of healthcare equipment and related supplies.

Pharmaceuticals (1,515)

Companies classified specifically in pharmaceuticals.

Biotechnology & Medical Research (1,179)

Companies and projects focused on biotechnology or medical research.

Healthcare Providers & Services (573)

Organizations providing healthcare or related services.

Questions to guide your research

  • What product, service or health-data function does the project provide?
  • Which development or operating milestones are documented in the profile and research?
  • What evidence and limitations does the author discuss?

Questions about this sector

Does this sector include biotechnology and medical devices?

Yes. The current application classification includes biotechnology and medical research, pharmaceuticals, healthcare equipment and supplies, and healthcare services and medical devices. The list below reflects the categories available in Orbitrum.

How can I find healthcare experts?

Open the authors attached to published evaluations or analysis of these projects. Their profiles show the work available on Orbitrum; a project category alone does not establish an author's medical qualifications.

Relevant research

Authors covering these projects

Explore related sectors